RecruitingNot ApplicableNCT05897099

Comprehensive HIV and Harm Prevention Via Telehealth

Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial


Sponsor

University of Miami

Enrollment

350 participants

Start Date

Oct 7, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether telehealth-based harm reduction services can help prevent HIV and reduce risky drug use behaviors among people who inject drugs and use needle exchange programs. **You may be eligible if...** - You are 18 or older and HIV-negative - You speak English or Spanish - You have used a syringe service program (needle exchange) at least twice in the past 3 months - You plan to stay in the local area for at least 12 months **You may NOT be eligible if...** - You tested positive for HIV - You are currently on medications for opioid use disorder (like methadone or buprenorphine) - You are already taking PrEP (HIV prevention medication) - You are currently in jail or prison - You have participated in a related clinical trial recently - You have signs or symptoms of a new HIV infection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALComprehensive Tele-harm Reduction

Comprehensive Tele-Harm Reduction is on-demand services including low-barrier access to PrEP, medications for substance use disorder and hepatitis C treatment. It includes mobile phlebotomy, peer harm reduction counseling, medication management, telehealth mental health/substance use disorder services-- all delivered via an syringe services program.

BEHAVIORALOff-site Linkage to HIV Prevention

The community engagement team is comprised of peers and social workers and provides the wraparound support needed.The team will assist participants in scheduling appointments at community health clinics. The community engagement team provides active clinic referral- that is, a member of the team will accompany patients to the first clinic visit.


Locations(2)

IDEA Miami

Miami, Florida, United States

IDEA Syringe Services Program

Miami, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05897099


Related Trials